Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;69(4):847-53.
doi: 10.1007/s13105-013-0261-8. Epub 2013 May 22.

The association of insulin resistance with serum osteoprotegerin in obese adolescents

Joanna Suliburska  1 , Pawel Bogdanski, Ewa Gajewska, Grazyna Kalmus, Magdalena Sobieska, Wlodzimierz Samborski
Affiliations

The association of insulin resistance with serum osteoprotegerin in obese adolescents

Joanna Suliburska et al. J Physiol Biochem. 2013 Dec.

Abstract

Some data indicate a potential relationship between insulin resistance level and the concentration of osteoprotegerin (OPG) in the body. There have been few studies concerning OPG level and its relationship with insulin resistance and body composition in young people. The aim of this study was to assess serum osteoprotegerin concentration in obese adolescents, and to evaluate its potential association with insulin resistance. Seventy-eight obese adolescents and 20 healthy volunteers aged 12-18 years were recruited in the study. Selected anthropometrical measurements and blood biochemical analyses were performed. Insulin resistance in the participants was evaluated according to the homeostasis model assessment-insulin resistance (HOMA-IR) protocol. Level of OPG was assessed in serum. Obese subjects had significantly higher HOMA-IR indices and OPG levels in serum than the control group. A significant positive correlation between OPG and insulin resistance was found. It was observed that high concentrations of osteoprotegerin are associated with insulin resistance in obese adolescents.

PubMed Disclaimer

References

    1. J Endocrinol Invest. 2013 Jan;36(1):16-20 - PubMed
    1. Cell. 1997 Apr 18;89(2):309-19 - PubMed
    1. Diabetologia. 2012 Dec;55(12):3145-51 - PubMed
    1. Diabetes Res Clin Pract. 2011 Jan;91(1):26-31 - PubMed
    1. Diabet Med. 1992 Jul;9(6):503-12 - PubMed

Publication types

LinkOut - more resources